{
  "id": "5e43090d48dab47f26000011",
  "type": "yesno",
  "question": "Are stem cell transplants used to treat acute kidney injury?",
  "ideal_answer": "Yes, stem cell transplantation is becoming the treatment of choice for complicated acute kidney injury.",
  "documents": [
    "http://www.ncbi.nlm.nih.gov/pubmed/25640064",
    "http://www.ncbi.nlm.nih.gov/pubmed/22892486",
    "http://www.ncbi.nlm.nih.gov/pubmed/28411358"
  ],
  "snippets": [
    {
      "text": "Animal studies have shown that mesenchymal stromal cell (MSC) infusions improve acute kidney injury (AKI) outcomes when administered early after ischemic/reperfusion injury or within 24 hours after cisplatin administration.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/25640064",
      "beginSection": "abstract",
      "endSection": "abstract"
    },
    {
      "text": "Early Diagnostic Markers for Detection of Acute Kidney Injury in Allogeneic Hematopoietic Stem Cell Transplant Recipients.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/28411358",
      "beginSection": "title",
      "endSection": "title"
    },
    {
      "text": "Risk assessment for acute kidney injury after allogeneic hematopoietic stem cell transplantation based on Acute Kidney Injury Network criteria.",
      "document": "http://www.ncbi.nlm.nih.gov/pubmed/22892486",
      "beginSection": "title",
      "endSection": "title"
    }
  ],
  "concepts": [],
  "exact_answer": "Yes"
}